700 patients110,866 observations180 daysLIVE

Patient P-02538

Synthetic patientMETA-24 · Day 179 · 55–64 · F · baseline S02Open companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
17%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S02
  2. Day 17 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 22 GI-04 recommendedGI Support Protocol GI-04
  4. Day 23 Patient acceptedStarted GI-04 in the companion
  5. Day 31 GI symptom burden −27% vs expectedGI Support Protocol GI-04
  6. Day 37 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 17.

Primary contributors, last 14 days
  • Nutritional resilience+4
  • Toxicity-4
  • GI instability-3
  • Treatment adherence+3
  • Inflammatory activity+2

What helped?

  • GI Support Protocol GI-04Day 22
    Result: symptom burden −27%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.3 · butyrate capacity 46/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
42 ms
Sleep
7.7 h
Steps
8,063
Resting HR
59 bpm
Daily log: GI score 22, nutritional resilience 63, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0221955%S1360
P-0264555%S02HY-01improved56
P-0233954%S03DT-01improved50
P-0203753%S04GI-04improved53
P-0235153%S1651
P-0223552%S14DT-01improved50
P-0204951%S1463
P-0207051%S1155
P-0250051%S14GI-04no change58
P-0270051%S0262
P-0226250%S1653
P-0233650%S2050